CAPITALIZING ON THE EMERGENCE OF PSYCHEDELIC MEDICINE FOR MENTAL HEALTH CONDITIONS
CSE: SHRM | FWB: 496 | OTC: SHRMF
Champignon is pursuing the development and commercialization of rapid onset treatments capable of improving health outcomes, such as depression and post-traumatic stress disorder (PTSD), as well as substance and alcohol use disorders. Champignon continues to be inspired by sustainability, as its medicinal mushroom-infused SKUs are organic, non- GMO and vegan certified.